100 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

9969

InnoCare Pharma
HK$5.3520.2%-40.4%HK$10.5bHK$9.73PS11.8xE23.7%n/a

503

Lansen Pharmaceutical Holdings
HK$1.790%23.6%HK$750.6mn/aPE13xn/a2.7%

897

Wai Yuen Tong Medicine Holdings
HK$0.230%-42.5%HK$258.8mn/aPE7.1xn/a0%

6990

Sichuan Kelun-Biotech Biopharmaceutical
HK$164.00-2.4%n/aHK$35.9bHK$184.04PS21.6xE22.9%n/a

2171

CARsgen Therapeutics Holdings
HK$6.1913.6%-50.0%HK$3.6bHK$7.20PB1.8xE20.4%n/a

2162

Keymed Biosciences
HK$35.602.0%-43.9%HK$9.8bHK$58.32PS25.8xE-8.6%n/a

1873

Viva Biotech Holdings
HK$0.6210.7%-60.0%HK$1.3bn/aPB0.3xn/an/a

9995

RemeGen
HK$29.80-2.3%-29.6%HK$26.7bHK$41.85PS11.9xE55.2%n/a

2257

Sirnaomics
HK$7.1213.0%-86.1%HK$618.1mHK$72.19PS1978.3xS58.2%n/a

2480

Beijing Luzhu Biotechnology
HK$27.00-4.6%n/aHK$5.5bHK$29.98PB5xE36.3%n/a

6185

CanSino Biologics
HK$21.7515.6%-38.7%HK$9.2bHK$26.96PS13.4xE138.2%0%

2126

JW (Cayman) Therapeutics
HK$1.9212.9%-44.7%HK$774.8mHK$2.72PS4.1xE28.3%n/a

6996

Antengene
HK$1.0614.0%-60.0%HK$715.4mHK$1.81PS9.8xE19.6%n/a

6628

Transcenta Holding
HK$1.811.7%-68.7%HK$735.8mHK$8.21PS12.7xE-2.4%n/a

8225

China Health Group
HK$0.1310.9%-32.3%HK$131.4mn/aPS5.7xn/an/a

8247

Biosino Bio-Technology and Science Incorporation
HK$0.90-4.3%-14.3%HK$130.2mn/aPB0.6xn/a0%

8329

Shenzhen Neptunus Interlong Bio-technique
HK$0.15-5.8%3.5%HK$246.7mn/aPE9.5xn/an/a

6660

AIM Vaccine
HK$8.887.6%-78.9%HK$10.8bHK$53.03PS8.4xS56.4%n/a

6955

Shandong Boan Biotechnology
HK$10.242.4%-39.6%HK$5.2bHK$11.30PS7.8xS27.8%n/a

1498

PuraPharm
HK$0.772.7%-28.0%HK$304.2mn/aPB2xn/a0%

1541

ImmuneOnco Biopharmaceuticals (Shanghai)
HK$14.06-6.9%n/aHK$5.3bHK$21.50PS12627xS58.1%n/a

1312

Kontafarma China Holdings
HK$0.0320%-20.0%HK$178.8mn/aPB0.2xn/a0%

6998

Genor Biopharma Holdings
HK$1.25-2.3%-32.8%HK$635.9mn/aPB0.5xn/an/a

950

Lee's Pharmaceutical Holdings
HK$1.189.3%-27.2%HK$694.8mHK$1.00PE41.6xS16.1%1.5%
Page 3 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.